Final 12 Teams Revealed: Which Innovators Caught the Eyes of Pfizer, Ping An, Tencent, and Legend Capital in the 'Healthcare Partners' Competition?
After passing the triple tests of registration, preliminary selection, and closed-door meetings, 12 teams finally defeated nearly 400 competitors to advance to the pitch session of the “Healthcare Partners” Innovative Collaboration Program Competition. On March 19, these 12 teams will sound the final horn in the Beijing “arena.”
Among the 12 teams shortlisted for the final pitch event of this competition, those focusing on medical technology and those emphasizing medical services each accounted for half. The cohort included both seasoned veterans from the internet healthcare sector, such as Palm Sugar Doctor (Zhangshang Tangyi) and Hangzhou Lianzhong, as well as rising stars like Jiuxin Medical (known for its automated external defibrillators).
Co-hosted by Pfizer China, Ping An Insurance, Tencent, and Legend Capital, this competition aims to integrate resources from all parties, enhance the healthcare ecosystem, achieve mutual benefits, explore innovative healthcare models that effectively benefit Chinese patients, and promote the development of China’s healthcare industry.
In accordance with the above principles, the Competition Organizing CommitteeComprehensive evaluation based on the project’s target market, business model, team background, and the completeness, attractiveness, and feasibility of its proposed collaboration plan., ultimately selecting these 12 projects from the 52 teams shortlisted for closed-door discussions.
As the final showdown approaches, these 12 teams are also making a unified debut on VCBeat, showcasing their strengths in all aspects (listed in no particular order).
"Global Imaging" Medical Cloud Service Platform
Hangzhou Lianzhong Medical Technology Co., Ltd.
Hangzhou Lianzhong Medical Technology Co., Ltd. is dedicated to technological advancement and service innovation in the field of internet healthcare. Its independently developed “Global Imaging” medical cloud service platform leverages big data collection, cloud storage, and secure, rapid, standardized transmission of medical images to meet a range of integrated healthcare needs, including remote consultations between hospitals, two-way patient referrals, and remote patient visits. By creating a complete online-to-offline closed loop, the platform enhances the networking, informatization, and mobility of healthcare institutions, as well as the efficiency of information-based diagnosis and treatment. It offers solutions to pressing social issues such as difficulty and high cost in accessing medical care, while exploring new models aligned with national healthcare reform policies.
Palm Sugar Doctor
Hangzhou Kangsheng Health Management Consulting Co., Ltd.
As a pioneer in the field of diabetes health management services, Zhangshang Tangyi is committed to building China’s largest one-stop management service platform for chronic diseases. By providing scientific, personalized medical service solutions and leveraging Alibaba Cloud’s big data for precise user engagement, we have helped nearly one million patients with diabetes and other chronic conditions improve their self-management and reclaim a healthy new life within just one year.
Mommy Knows
Shenzhen Medinfo Technology Co., Ltd.
Mami Zhidao is an online consultation platform for mothers and infants, launched by Yixin Technology in 2015. The platform has exclusive contracts with obstetricians and pediatricians from Grade A tertiary hospitals in key cities across China, offering online waiting rooms and responsive consultations to address health concerns for both mothers and babies. Additionally, Mami Zhidao insists on original content created by doctors, providing a vast amount of popular science information to help mothers comprehensively master childcare knowledge. Mami Zhidao enables mothers to consult doctors from the comfort of their homes.
Ear Care Era
Beijing Aier Shidai Education Consulting Co., Ltd.
iHear Era is China’s largest hearing healthcare platform. Founded in 2013, it is committed to building an international, high-quality brand for hearing healthcare services, integrating superior professional hearing resources from both domestic and overseas markets, and meeting the hearing care needs of individuals with hearing loss in China. With international training backgrounds and globally recognized credentials, iHear Era audiologists focus on providing one-stop, comprehensive, and professional hearing solutions for Chinese families. Its subsidiaries include: China Hearing Online, iHear Era Hearing Academy, and iHear Era International Hearing Center.
Gairui Technology
Beijing Gairui Technology Co., Ltd.
Gairui Technology is a high-tech enterprise specializing in the research and development, sales, value-added business management, and operation of mobile healthcare products. Leveraging its strong capabilities in medical product R&D and deep technical expertise in the mobile internet sector, the company has successfully built comprehensive healthcare and health management service solutions—covering health tracking, chronic disease management, and telemedicine services—within two key areas: tiered diagnosis and treatment at the primary care level, and personal health management services. By deploying its business through micro-testing and cloud-based consultations, Gairui has established an online cloud platform complemented by offline micro-testing centers. Its services now reach nearly 20 provinces across China, making it a leading provider of mobile healthcare services and solutions in the country.
"Renowned Physician-Led Surgery"
Shanghai Chuangxian Network Technology Co., Ltd.
Mingyi Zhudao is China’s largest mobile surgical platform, dedicated to providing professional, efficient, and safe surgical services to patients in need of operations by facilitating appointments with renowned specialists. Headquartered in Shanghai with branches in multiple cities, the company’s services cover all of China. The platform aggregates top-tier medical experts from both domestic and international markets, as well as underutilized hospital bed resources. By leveraging internet technology, it achieves precise matching between patients and physicians and optimizes the allocation of medical resources, thereby addressing patients’ practical needs for accessible and high-quality care. Since its inception, Mingyi Zhudao has actively responded to government policies promoting multi-site practice and tiered diagnosis and treatment. Its operational philosophy aligns with the sharing economy model, which is currently gaining prominence both domestically and internationally, creating a win-win situation for patients, physicians, and hospitals.
Nuohui
Hangzhou New Horizon Health Technology Co., Ltd.
New Horizon Launches an Internet-Plus Early Diagnosis and Treatment Technology for Colorectal Cancer: Colotect Clear. This is a novel, non-invasive, painless, and home-based genetic testing technology. By analyzing fecal DNA, Colotect Clear can detect precancerous colorectal lesions larger than 1 cm in diameter, identifying lesions five years earlier than conventional health screenings. Colotect Clear provides a simple and practical solution for the early detection of colorectal cancer, and its widespread adoption has the potential to significantly reduce colorectal cancer mortality rates across China.
Handheld HbA1c Analyzer
Wuxi Bohuis Biopharmaceutical Technology Co., Ltd.
Wuxi Bihuis Biopharmaceutical Technology Co., Ltd. was established in 2006 and is among the first batch of “530” high-tech biomedical enterprises introduced to the Mashan National Life Science Park in Wuxi, Jiangsu Province. The company specializes in the research, development, and production of in vitro diagnostic technologies and products, providing rapid, accurate, simple, and reliable diagnostic solutions for public health. Bihuis currently holds patented technologies in more than 20 countries worldwide, and has launched three major product series—“Botangping,” “Huiankang,” and “Taiankang”—in the Chinese market, focusing on chronic diseases and obstetrics and gynecology.
Novel Rapid Combined Diagnostic Product for Early Detection of Invasive Fungal Disease (IFD)
Dena (Tianjin) Biotechnology Co., Ltd.
Diana Biologics was founded in March 2014 by Dr. Zhou Zeqi, a globally renowned expert in in vitro diagnostics (IVD), a leading talent in the Beijing-Tianjin-Hebei region, and an affiliate of Harvard Medical School, with a registered capital of RMB 46 million. The company is dedicated to the research and development of new technologies for the early, rapid, and combined detection of invasive fungal diseases (IFD). It is the only company worldwide to propose a combined detection solution and provide a complete product portfolio. Five of its products have obtained registration certificates from the China Food and Drug Administration (CFDA), and nine have received CE certification. Equipped with both fully automated and semi-automated fungal combined detection analyzers, its solutions have been implemented in 120 key hospitals across China. Furthermore, the company has established partnerships with 40 distributors in 30 countries, demonstrating strong international competitiveness and significant growth potential.
"Tumor Hunter" -- Peptide Nanomagnetic Bead Technology for Detecting Circulating Tumor Cells (CTCs) in Peripheral Blood
Beijing Zhongke Natai Biotechnology Co., Ltd.
Zhongke Natai is a nanobiotechnology company dedicated to advancing liquid biopsy technologies. Leveraging the scientific research strength of the National Center for Nanoscience and Technology of the Chinese Academy of Sciences, and building on nanotechnologies characterized by “high-throughput,” “microfluidics,” and “microarrays,” the company continuously develops medical products with independent intellectual property rights, providing early cancer diagnosis and precision medicine research services. Its “Tumor Hunter”—a peptide-coated magnetic nanoparticle-based technology for detecting circulating tumor cells (CTCs) in peripheral blood—has received numerous awards both domestically and internationally.
Automated External Defibrillator (AED)
Jiu Xin Medical Technology (Suzhou) Co., Ltd.
JiuXin Medical Technology (Suzhou) Co., Ltd. is committed to becoming a global professional provider of emergency resuscitation products and solutions. JiuXin Medical has developed a series of Automated External Defibrillators (AEDs), creating a comprehensive monitoring-treatment survival chain by applying remote management systems based on mobile internet technology and wearable vital signs monitoring systems for individual users. Through professional and reliable products and services, JiuXin Medical provides safe life protection for cardiac patients.
Hiskel Liver Health Management Platform
Wuxi Hisky Medical Technology Co., Ltd.
Haiskaler has developed FibroTouch, a non-invasive quantitative detection system for liver fibrosis based on transient elastography technology. This system overcomes the limitations of clinical liver biopsy and provides a new non-invasive, rapid, quantitative, and cost-effective solution for liver fibrosis assessment to the 280 million people in China with liver injury. Furthermore, by using the device as a connectivity hub and leveraging big data and mobile health technologies, it establishes a closed-loop data ecosystem among patients, devices, and physicians, thereby enabling effective management of chronic liver diseases. Targeting liver disease as a global public health challenge, the project offers solutions for early detection, early intervention, and early recovery from both equipment and data perspectives, serving the liver disease population and reducing societal costs.
——————Important News Separator——————
March 19, 2016,The “Medical Partners ‘Innovative Collaboration Proposal Competition’ Roadshow Event” is about to be held atBeijingHeld with an impressive lineup of industry leaders and stars, VCBeat will provide on-site coverage. We encourage our readers to stay tuned!
See below for the event agenda
A limited number of spots are still available for this event. Interested VCBeat community members may leave a message in the backend of the “VCBeat” WeChat official account, noting: “Medical Partner Attendance + Name + Organization + Title + Mobile Number + Email Address.”